How Do "Must-Access" Prescription Drug Monitoring Programs Address Opioid Misuse?

被引：3

作者：

Ukert, Benjamin ^{[1
,2
]}

Polsky, Daniel ^{[3
]}

机构：

[1] Texas A&M Univ, College Stn, TX 77843 USA

[2] Elevance Hlth, Indianapolis, IN 46204 USA

[3] Johns Hopkins Univ, Baltimore, MD USA

来源：

AMERICAN JOURNAL OF HEALTH ECONOMICS | 2023年 / 9卷 / 03期

关键词：

opioids; PDMPs; commercially insured; UNITED-STATES; IMPACT; OVERDOSE; TRENDS; RISK; PAIN;

D O I：

10.1086/722979

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

The opioid epidemic led to the creation of state Prescription Drug Monitoring Programs (PDMPs) that eventually mandated access. We examine how these "must-access" PDMPs influenced prescribing after an emergency department (ED) visit and in the long term for the working-age population. By using data from a large multistate commercial insurance database from 2010 to 2014 and estimating difference-in-differences models, we show that only the broadest must-access PDMPs reduced opioid prescribing after an ED visit and in the long term. We then compared changes in prescribing rates for opioid naive relative to non-opioid naive individuals to disentangle the influence of information from administration costs on prescriber behavior. Findings suggest that hassle cost explains the majority of the decline in initial prescribing, and that the information value drives most of the reduction in long-term outcomes.

引用

页码：374 / 404

页数：31

共 45 条

[21] Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates [J].

Dowell, Deborah ;

Zhang, Kun ;

Noonan, Rita K. ;

Hockenberry, Jason M. .

HEALTH AFFAIRS, 2016, 35 (10) :1876-1883

[22] Opioid Prescriptions for Chronic Pain and Overdose A Cohort Study [J].

Dunn, Kate M. ;

Saunders, Kathleen W. ;

Rutter, Carolyn M. ;

Banta-Green, Caleb J. ;

Merrill, Joseph O. ;

Sullivan, Mark D. ;

Weisner, Constance M. ;

Silverberg, Michael J. ;

Campbell, Cynthia I. ;

Psaty, Bruce M. ;

Von Korff, Michael .

ANNALS OF INTERNAL MEDICINE, 2010, 152 (02) :85-+

[23] Comorbidity measures for use with administrative data [J].

Elixhauser, A ;

Steiner, C ;

Harris, DR ;

Coffey, RN .

MEDICAL CARE, 1998, 36 (01) :8-27

[24] Difference-in-differences with variation in treatment timing [J].

Goodman-Bacon, Andrew .

JOURNAL OF ECONOMETRICS, 2021, 225 (02) :254-277

[25] What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose [J].

Haegerich, Tamara M. ;

Paulozzi, Leonard J. ;

Manns, Brian J. ;

Jones, Christopher M. .

DRUG AND ALCOHOL DEPENDENCE, 2014, 145 :34-47

[26] Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages [J].

Haffajee, Rebecca L. ;

Mello, Michelle M. ;

Zhang, Fang ;

Zaslavsky, Alan M. ;

Larochelle, Marc R. ;

Wharam, J. Frank .

HEALTH AFFAIRS, 2018, 37 (06) :964-974

[27]

Healthcare Cost Institute, 2022, DATA

[28] An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions [J].

Islam, M. Mofizul ;

McRae, Ian S. .

BMC PHARMACOLOGY & TOXICOLOGY, 2014, 15

[29] Hospital Prescribing of Opioids to Medicare Beneficiaries [J].

Jena, Anupam B. ;

Goldman, Dana ;

Karaca-Mandic, Pinar .

JAMA INTERNAL MEDICINE, 2016, 176 (07) :990-997

[30] State Legal Restrictions and Prescription-Opioid Use among Disabled Adults [J].

Meara, Ellen ;

Horwitz, Jill R. ;

Powell, Wilson ;

McClelland, Lynn ;

Zhou, Weiping ;

O'Malley, A. James ;

Morden, Nancy E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (01) :44-53

← 1 2 3 4 5 →